FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2128406977> ?p ?o ?g. }

• W2128406977 endingPage "80" @default.
• W2128406977 startingPage "76" @default.
• W2128406977 abstract "To determine the prevalence of and risk factors for primary hypothyroidism following treatment with a radiolabeled monoclonal antibody ((131)I-3F8) in children with neuroblastoma.In the current study, we assessed thyroid function in 51 neuroblastoma patients who survived for > or =3 months after treatment with (131)I-3F8 (a murine IgG3 monoclonal antibody that reacts with the ganglioside GD2) at 4 mCi/kg/day x 5 days (total 20 mCi/kg). Prior therapy in all subjects included dose-intensive chemotherapy; 13 subjects also received external beam radiation to the neck. Oral iodide and liothyronine sodium (T3) were administered for protection of the thyroid gland.Thirty-two of 51 subjects (63%) developed hormonal evidence of primary hypothyroidism. The median time to hypothyroidism after treatment with (131)I-3F8 was 6.4 months. The probability of developing hypothyroidism was 56% at 2 years following treatment with (131)I-3F8. There was evidence for an association between thyroidal uptake of (131)I and development of hypothyroidism (hazard ratio 1.83, 95% confidence interval 0.91-3.30; P = 0.09).We conclude that hormonal evidence of primary hypothyroidism developed in a majority of subjects treated with (131)I-3F8, despite pretreatment with oral iodide plus liothyronine sodium. Alternative strategies for thyroid gland protection are needed." @default.
• W2128406977 created "2016-06-24" @default.
• W2128406977 creator A5015396908 @default.
• W2128406977 creator A5018167887 @default.
• W2128406977 creator A5031035765 @default.
• W2128406977 creator A5034081882 @default.
• W2128406977 creator A5034325765 @default.
• W2128406977 creator A5043729995 @default.
• W2128406977 creator A5050680844 @default.
• W2128406977 creator A5063077038 @default.
• W2128406977 creator A5063829444 @default.
• W2128406977 date "2010-03-08" @default.
• W2128406977 modified "2023-10-09" @default.
• W2128406977 title "Hypothyroidism after ¹³¹ I-monoclonal antibody treatment of neuroblastoma" @default.
• W2128406977 cites W1535107443 @default.
• W2128406977 cites W1960710326 @default.
• W2128406977 cites W1992027081 @default.
• W2128406977 cites W1994092038 @default.
• W2128406977 cites W2020072989 @default.
• W2128406977 cites W2025329294 @default.
• W2128406977 cites W2039990819 @default.
• W2128406977 cites W2045726657 @default.
• W2128406977 cites W2059891370 @default.
• W2128406977 cites W2067606868 @default.
• W2128406977 cites W2094726282 @default.
• W2128406977 cites W2106739013 @default.
• W2128406977 cites W2111474003 @default.
• W2128406977 cites W2124670971 @default.
• W2128406977 cites W2128282305 @default.
• W2128406977 cites W2133606662 @default.
• W2128406977 cites W2139980527 @default.
• W2128406977 cites W2150708035 @default.
• W2128406977 cites W2159103399 @default.
• W2128406977 cites W2164970068 @default.
• W2128406977 cites W2312664798 @default.
• W2128406977 cites W2327522594 @default.
• W2128406977 cites W4234934721 @default.
• W2128406977 cites W4243760006 @default.
• W2128406977 cites W4254756961 @default.
• W2128406977 doi "https://doi.org/10.1002/pbc.22452" @default.
• W2128406977 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20213847" @default.
• W2128406977 hasPublicationYear "2010" @default.
• W2128406977 type Work @default.
• W2128406977 sameAs 2128406977 @default.
• W2128406977 citedByCount "5" @default.
• W2128406977 countsByYear W21284069772013 @default.
• W2128406977 countsByYear W21284069772015 @default.
• W2128406977 countsByYear W21284069772022 @default.
• W2128406977 countsByYear W21284069772023 @default.
• W2128406977 crossrefType "journal-article" @default.
• W2128406977 hasAuthorship W2128406977A5015396908 @default.
• W2128406977 hasAuthorship W2128406977A5018167887 @default.
• W2128406977 hasAuthorship W2128406977A5031035765 @default.
• W2128406977 hasAuthorship W2128406977A5034081882 @default.
• W2128406977 hasAuthorship W2128406977A5034325765 @default.
• W2128406977 hasAuthorship W2128406977A5043729995 @default.
• W2128406977 hasAuthorship W2128406977A5050680844 @default.
• W2128406977 hasAuthorship W2128406977A5063077038 @default.
• W2128406977 hasAuthorship W2128406977A5063829444 @default.
• W2128406977 hasBestOaLocation W21284069771 @default.
• W2128406977 hasConcept C126322002 @default.
• W2128406977 hasConcept C134018914 @default.
• W2128406977 hasConcept C187212893 @default.
• W2128406977 hasConcept C2776715637 @default.
• W2128406977 hasConcept C2779761222 @default.
• W2128406977 hasConcept C509974204 @default.
• W2128406977 hasConcept C526584372 @default.
• W2128406977 hasConcept C54355233 @default.
• W2128406977 hasConcept C71315377 @default.
• W2128406977 hasConcept C71924100 @default.
• W2128406977 hasConcept C81885089 @default.
• W2128406977 hasConcept C86803240 @default.
• W2128406977 hasConcept C90924648 @default.
• W2128406977 hasConceptScore W2128406977C126322002 @default.
• W2128406977 hasConceptScore W2128406977C134018914 @default.
• W2128406977 hasConceptScore W2128406977C187212893 @default.
• W2128406977 hasConceptScore W2128406977C2776715637 @default.
• W2128406977 hasConceptScore W2128406977C2779761222 @default.
• W2128406977 hasConceptScore W2128406977C509974204 @default.
• W2128406977 hasConceptScore W2128406977C526584372 @default.
• W2128406977 hasConceptScore W2128406977C54355233 @default.
• W2128406977 hasConceptScore W2128406977C71315377 @default.
• W2128406977 hasConceptScore W2128406977C71924100 @default.
• W2128406977 hasConceptScore W2128406977C81885089 @default.
• W2128406977 hasConceptScore W2128406977C86803240 @default.
• W2128406977 hasConceptScore W2128406977C90924648 @default.
• W2128406977 hasIssue "1" @default.
• W2128406977 hasLocation W21284069771 @default.
• W2128406977 hasLocation W21284069772 @default.
• W2128406977 hasOpenAccess W2128406977 @default.
• W2128406977 hasPrimaryLocation W21284069771 @default.
• W2128406977 hasRelatedWork W165683302 @default.
• W2128406977 hasRelatedWork W1974317126 @default.
• W2128406977 hasRelatedWork W2021744816 @default.
• W2128406977 hasRelatedWork W2164731895 @default.
• W2128406977 hasRelatedWork W2331058431 @default.
• W2128406977 hasRelatedWork W2444221640 @default.
• W2128406977 hasRelatedWork W2473527778 @default.

• next